Human papillomavirus risk factors for infection and genotype distribution in aboriginal women from Northern Argentina;Virus papiloma humano (HPV) en mujeres de la etnia pilagá del nordeste Argentino: Factores de riesgo de infección y distribución de tipos virales

Medicina (Argentina)

Volumn 72, Issue 6, 2012, Pages 461-466

  Deluca, Gerardo D ^a   Basiletti, Jorge ^b   González, Joaquín V ^b   Vásquez, Nicolás Díaz ^c   Lucero, Raúl H ^c   Picconi, María A ^b  

^a UNIVERSIDAD NACIONAL DEL NORDESTE   (Argentina)

^b INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

^c UNIVERSIDAD NACIONAL DEL NORDESTE   (Argentina)

Author keywords

Aboriginal women; Human papillomavirus infection; Viral sexually transmitted disease

Indexed keywords

VIRUS DNA;

ABORIGINE; ADOLESCENT; ADULT; AGED; ARGENTINA; ARTICLE; ASIAN AMERICAN; EUROPEAN AMERICAN; FEMALE; GENETIC VARIABILITY; GENOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 6; INFECTION RISK; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRECANCER; PREVALENCE; RISK ASSESSMENT; UTERINE CERVIX CYTOLOGY; VIRUS ENTRY; VIRUS GENE; ETHNIC AND RACIAL GROUPS; ETHNOLOGY; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPANICOLAOU TEST; PAPILLOMA VIRUS; PATHOLOGY; RISK FACTOR; SOCIOECONOMICS; UTERINE CERVIX; UTERINE CERVIX TUMOR; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ARGENTINA; CERVIX UTERI; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; PAPANICOLAOU TEST; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POPULATION GROUPS; PRECANCEROUS CONDITIONS; PREVALENCE; RISK FACTORS; SOCIOECONOMIC FACTORS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84872142266     PISSN: 00257680     EISSN: 16699106     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007; 370: 890-907.
2. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 2007; 90: 1-636.
3. Muñoz N, Bosch FX, de Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-527.
4. Bruni L, Díaz M, Castellsagué X, Ferrer E, Bosch FX, de Sanjosé S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 2010; 202: 1789-1799.
5. Clifford GM, Smith JS, Aguado T, Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 2003; 89: 101-105.
6. Arrossi S, Ramos S, Paolino M, Sankaranarayanan R. Social inequality in Pap smear coverage: identifying under-users of cervical cancer screening in Argentina. Reprod Health Matters 2008; 16: 50-58.
7. Arrossi S. Proyecto para el mejoramiento del Programa Nacional de Prevención de Cáncer de Cuello Uterino en Argentina. Informe final: Diagnóstico de situación del Programa Nacional y Programas Provinciales. 1° ed. Buenos Aires: Organización Panamericana de la Salud, OPS; 2008. In: http://www.msal.gov.ar/cancer-cervicouterino/pdf/info-equipos-salud/Diagnostico_Pub64_OPS.pdf (last accessed 14-11-2011).
8. Bernard HU, Chan SY, Manos MM, et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 1994; 170: 1077-1085.
9. Manos MM, Ting Y, Wright DK, Lewis AJ, Brocker TR, Wolinsky SM. The use of polymerase chain reaction amplification for the detection of genital human papillomavirus. Cancer Cells 1989; 7: 209-214.
10. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995; 76 (Pt 4): 1057-1062.
11. Ho L, Chan SY, Burk RD, et al. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol 1993; 67: 6413-6423.
12. Picconi MA, Gronda J, Alonio LV, et al. Human Papilloma virus in Quechua women from Jujuy with high frequency of cervical cancer: viral types and HPV-16 variants. Medicina (B Aires) 2002; 62: 209-220.
13. Tonon SA, Picconi MA, Zinovich JB, et al. Human papillomavirus cervical infection in Guarani Indians from the rainforest of Misiones, Argentina. Int J Infect Dis 2004; 8: 13-19.
14. Soto-De Leon S, Camargo M, Sanchez R, et al. Distribution patterns of infection with multiple types of human papillomaviruses and their association with risk factors. PLoS One 2011; 6: e14705.
15. Brito EB, Silva ID, Stávale JN, Taromaru E, Menezess RC, Martins SJ. Amerindian women of the Brazilian Amazon and STD. Eur J Gynaecol Oncol 2006; 27: 279-281.
16. Kightlinger RS, Irvin WP, Archer KJ, et al. Cervical cancer and human papillomavirus in indigenous Guyanese women. Am J Obstet Gynecol 2010; 202: 626. e1-e7.
17. de Sanjosé S, Díaz M, Castellsagué X, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007; 7: 453-459.
18. Parkin DM, Almonte M, Bruni L, Clifford G, Curado MP, Piñeros M. Burden and trends of type-specific human papillomavirus infections and related diseases in the Latin America and Caribbean region. Vaccine 2008; 26: L1-L15.
19. Almonte M, Albero G, Molano M, Carcamo C, García PJ, Pérez G. Risk factors for human papillomavirus exposure and co-factors for cervical cancer in Latin America and the Caribbean. Vaccine 2008; 26: L16-L36.
20. Lippman SA, Sucupira MCA, Jones HE, et al. Prevalence, distribution and correlates of endocervical human papillomavirus types in Brazilian women. Int J STD AIDS 2010; 21: 105-109.
21. Franceschi S, Herrero R, Clifford GM, et al. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer 2006; 119: 2677-2684.
22. Smith JS, Melendy A, Rana RK, Pimenta JM. Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health 2008; 43: S5-25, S25. e1-41.
23. Franceschi S, Rajkumar R, Snijders PJF, et al. Papillomavirus infection in rural women in southern India. Br J Cancer 2005; 92: 601-606.
24. Muñoz N, Méndez F, Posso H, et al. Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J Infect Dis 2004; 190: 2077-2087.
25. Tábora N, Bakkers JM, Quint WG, et al. Human papillomavirus infection in Honduran women with normal cytology. Cancer Causes Control 2009; 20: 1663-1670.
26. Spinillo A, Dal Bello B, Gardella B, Roccio M, Dacco MD, Silini EM. Multiple human papillomavirus infection and high grade cervical intraepithelial neoplasia among women with cytological diagnosis of atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions. Gynecol Oncol 2009; 113: 115-119.
27. Trottier H, Mahmud S, Costa MC, et al. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomarkers Prev 2006; 15: 1274-1280.
28. Bello BD, Spinillo A, Alberizzi P, et al. Cervical infections by multiple human papillomavirus (HPV) genotypes: Prevalence and impact on the risk of precancerous epithelial lesions. J Med Virol 2009; 81: 703-712.
29. Sichero L, Ferreira S, Trottier H, et al. High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int J Cancer 2007; 120: 1763-1768.
30. Xi LF, Koutsky LA, Hildesheim A, et al. Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18. Cancer Epidemiol Biomarkers Prev 2007; 16: 4-10.
31. Sichero L, Villa LL. Epidemiological and functional implications of molecular variants of human papillomavirus. Braz J Med Biol Res 2006; 39: 707-717.
32. Tonon SA, Basiletti J, Badano I, et al. Human papillomavirus type 16 molecular variants in Guarani Indian women from Misiones, Argentina. Int J Infect Dis 2007; 11: 76-81.
33. Picconi MA, Alonio LV, García Carrancá A, et al. Molecular variants of human papillomavirus (HPV) types 16 and 18 in adenocarcinomas of the cervix. Medicina (B Aires) 2000; 60: 889-894.
34. Alencar TR, Cerqueira DM, da Cruz MR, Wyant PS, Ramalho ED, Martins CR. New HPV-16 European and non-European variants in Central Brazil. Virus Genes 2007; 35: 1-4.